Matches in Nanopublications for { ?s ?p "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP630545.RAC2WnCOlrn3tFG318pyrv5mp0UljydcJTAKsmMwWiHL4130_assertion description "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630545.RAC2WnCOlrn3tFG318pyrv5mp0UljydcJTAKsmMwWiHL4130_provenance.
- NP837712.RAe0rE5BlJo9hhad8jvJvnJcfhaww_v_VZQzeJh0Nu2lA130_assertion description "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP837712.RAe0rE5BlJo9hhad8jvJvnJcfhaww_v_VZQzeJh0Nu2lA130_provenance.
- assertion description "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_assertion description "[Furthermore, asymptomatic carriers with the ALK1 mutation within the serine - threonine kinase domain are at risk of developing PAH and hereditary hemorrhagic telangiectasia, so close follow-up is recommended for those individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647017.RA1uKvC7gFHS5uAq3HvThgBN_tYmgTuiBG4ukpVBHdOU0130_provenance.